BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 35324674)

  • 1. The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction.
    Cunha RSD; Azevedo CAB; Falconi CA; Ruiz FF; Liabeuf S; Carneiro-Ramos MS; Stinghen AEM
    Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance.
    Daneshamouz S; Eduok U; Abdelrasoul A; Shoker A
    NanoImpact; 2021 Jan; 21():100299. PubMed ID: 35559786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition and clinical implications of protein-bound uremic toxins.
    Jansen J; Jankowski J; Gajjala PR; Wetzels JFM; Masereeuw R
    Clin Sci (Lond); 2017 Jul; 131(14):1631-1647. PubMed ID: 28667064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kidney and uremic toxin removal: glomerulus or tubule?
    Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
    Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailing Protein-Bound Uremic Toxin Interaction Mechanisms with Human Serum Albumin in the Pursuit of Designing Competitive Binders.
    Dehghan Niestanak V; Unsworth LD
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
    Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-brain barrier perturbations by uremic toxins: Key contributors in chronic kidney disease-induced neurological disorders?
    Faucher Q; van der Made TK; De Lange E; Masereeuw R
    Eur J Pharm Sci; 2023 Aug; 187():106462. PubMed ID: 37169097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adsorption- and Displacement-Based Approaches for the Removal of Protein-Bound Uremic Toxins.
    Rodrigues FSC; Faria M
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do Uremic Toxins Affect the Endothelium?
    Cunha RSD; Santos AF; Barreto FC; Stinghen AEM
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32575762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs Commonly Applied to Kidney Patients May Compromise Renal Tubular Uremic Toxins Excretion.
    Mihaila SM; Faria J; Stefens MFJ; Stamatialis D; Verhaar MC; Gerritsen KGF; Masereeuw R
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32545617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
    Black AP; Cardozo LF; Mafra D
    Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibuprofen-Immobilized Thin Films: A Novel Approach to Improve the Clearance of Protein-Bound Uremic Toxins.
    Rodrigues FSC; Brilhante D; MacĂȘdo A; Pires RF; Faria M
    ACS Appl Mater Interfaces; 2024 Feb; 16(5):6589-6604. PubMed ID: 38282580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uremic Toxins and Protein-Bound Therapeutics in AKI and CKD: Up-to-Date Evidence.
    Chen JH; Chiang CK
    Toxins (Basel); 2021 Dec; 14(1):. PubMed ID: 35050985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins.
    Guo J; Lu L; Hua Y; Huang K; Wang I; Huang L; Fu Q; Chen A; Chan P; Fan H; Liu ZM; Wang BH
    Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H1-H13. PubMed ID: 28411233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dual Roles of Protein-Bound Solutes as Toxins and Signaling Molecules in Uremia.
    Masereeuw R
    Toxins (Basel); 2022 Jun; 14(6):. PubMed ID: 35737063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adsorption capacity of poly(ether imide) microparticles to uremic toxins.
    Tetali SD; Jankowski V; Luetzow K; Kratz K; Lendlein A; Jankowski J
    Clin Hemorheol Microcirc; 2016; 61(4):657-65. PubMed ID: 26639769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut-Derived Protein-Bound Uremic Toxins.
    Graboski AL; Redinbo MR
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using binding competitors of albumin to promote the removal of protein-bound uremic toxins in hemodialysis: Hope or pipe dream?
    Florens N; Yi D; Juillard L; Soulage CO
    Biochimie; 2018 Jan; 144():1-8. PubMed ID: 28987629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved dialytic removal of protein-bound uremic toxins by intravenous lipid emulsion in chronic kidney disease rats.
    Shi Y; Zhang Y; Tian H; Wang Y; Shen Y; Zhu Q; Ding F
    Nephrol Dial Transplant; 2019 Nov; 34(11):1842-1852. PubMed ID: 31071223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-Dependent Protein Binding Properties of Uremic Toxins In Vitro.
    Yamamoto S; Sasahara K; Domon M; Yamaguchi K; Ito T; Goto S; Goto Y; Narita I
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33557434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.